Ganoderma lucidum in cancer research

Leukemia Research

Volumn 30, Issue 7, 2006, Pages 767-768

  Sliva, Daniel ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GANODERMA LUCIDUM EXTRACT; PROTEIN P21; PROTEIN P27;

APOPTOSIS; CANCER CELL CULTURE; CANCER CONTROL; CANCER INHIBITION; CANCER INVASION; CANCER PREVENTION; CANCER RESEARCH; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL STRAIN HL 60; CYTOKINE PRODUCTION; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; GANODERMA LUCIDUM; HUMAN; IMMUNOSTIMULATION; LEUKEMIA CELL; MEDICINAL PLANT; MITOSIS INHIBITION; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

APOPTOSIS; BIOMEDICAL RESEARCH; CELL LINE, TUMOR; CELL PROLIFERATION; DRUGS, CHINESE HERBAL; HUMANS; LEUKEMIA; REISHI;

EID: 33744519397     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.12.015     Document Type: Editorial

References (25)

1. Yun T.K. Update from Asia. Asian studies on cancer chemoprevention. Ann N Y Acad Sci 889 (1999) 157-192
2. Shiao M.S., Lee K.R., Lin L.J., and Wang C.T. Natural products and biological activities of the Chinese medical fungus, Ganoderma lucidum. In: Ho C.T., Osawa T., Huang M.T., and Rosen R.T. (Eds). Food phytochemicals for cancer prevention. II. Teas, spices, and herbs (1994), American Chemical Society, Washington, DC 342-354
3. Sliva D. Cellular and physiological effects of Ganoderma lucidum (Reishi). Mini-Rev Med Chem 4 (2004) 873-879
4. Eisenberg D.M., Davis R.B., Ettner S.L., Appel S., Wilkey S., Van Rompay M., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 (1998) 1569-1575
5. Min B.S., Gao J.J., Nakamura N., and Hattori M. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 48 (2000) 1026-1033
6. Miyazaki T., and Nishijima M. Studies on fungal polysaccharides. XXVII. Structural examination of a water-soluble, antitumor polysaccharide of Ganoderma lucidum. Chem Pharmacol Bull 29 (1981) 3611-3616
7. Sone Y., Okuda R., Wada N., Kishida E., and Misaki A. Structures and antitumor activities of the polysaccharides isolated from fruiting body and the growing culture of mycelium of Ganoderma lucidum. Agric Biol Chem 49 (1985) 2641-2653
8. Lin W.H., Hung C.H., Hsu C.I., and Lin J.Y. Dimerization of the N-terminal amphipathic alpha-helix domain of the fungal immunomodulatory protein from Ganoderma tsugae (Fip-gts) defined by a yeast two-hybrid system and site-directed mutagenesis. J Biol Chem 272 (1997) 20044-20048
9. Mizushina Y., Hanashima L., Yamaguchi T., Takemura M., Sugawara F., Saneyoshi M., et al. A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun 249 (1998) 17-22
10. Lee S., Park S., Oh J.W., and Yang C. Natural inhibitors for protein prenyltransferase. Planta Med 64 (1998) 303-308
11. Wang S.Y., Hsu M.L., Hsu H.C., Lee S.S., Shiao M.S., and Ho C.K. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer 70 (1997) 699-705
12. Sliva D., Labarrere C., Slivova V., Sedlak M., Lloyd Jr. F.P., and Ho NW.Y. Ganoderma lucidum suppresses motility of highly invasive breast and prostate cancer cells. Biochem Biophys Res Commun 298 (2002) 603-612
13. Slivova V., Valachovicova T., Jiang J., and Sliva D. Ganoderma lucidum inhibits invasiveness of breast cancer cells. J Cancer Integr Med 2 (2004) 25-30
14. Jiang J., Slivova V., Harvey K., Valachovicova T., and Sliva D. Ganoderma lucidum suppresses growth of breast cancer cells through the inhibition of Akt/NF-κB signaling. Nutr Cancer 49 (2004) 209-216
15. Hu H., Ahn N.S., Yang X., Lee Y.S., and Kang K.S. Ganoderma lucidum extract induces cell cycle arrest and apoptosis in MCF-7 human breast cancer cell. Int J Cancer 102 (2002) 250-253
16. Jiang J., Slivova V., Valachovicova T., Harvey K., and Sliva D. Ganoderma lucidum inhibits proliferation and induces apoptosis in human prostate cancer cells PC-3. Int J Oncol 24 (2004) 1093-1100
17. Lin S.B., Li C.H., Lee S.S., and Kan L.S. Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci 72 (2003) 2381-2390
18. Hong K.J., Dunn D.M., Shen C.L., and Pence B.C. Effects of Ganoderma lucidum on apoptotic and anti-inflammatory function in HT-29 human colonic carcinoma cells. Phytother Res 18 (2004) 768-770
19. Stanley G., Harvey K., Slivova V., Jiang J., and Sliva D. Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-β1 from prostate cancer cells. Biochem Biophys Res Commun 330 (2005) 46-52
20. Müller C.I., Kumagai T., O'Kelly J., Seeram N.P., Heber D., and Koeffler H.P. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res 30 (2006) 841-848
21. Hattori M. Recent studies on the bitter principles of Ganoderma lucidum-isolation of novel triterpenes, their biological activity and pharmacokinetics. Proceedings of international symposium of Ganoderma science. Auckland, 27-29 April (2001)
22. Sliva D., Sedlak M., Slivova V., Valachovicova T., Lloyd Jr. F.P., and Ho NW.Y. Biologic activity of Ganoderma lucidum for the inhibition of highly invasive breast and prostate cancer cells. J Altern Complement Med 9 (2003) 491-497
23. Wilasrumee C., Kittur S., Siddiqui J., Bruch D., Wilasrumee S., and Kittur D.S. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes. J Altern Complement Med 8 (2002) 467-475
24. Williamson E.M. Synergy and other interactions in phytomedicines. Phytomedicine 8 (2001) 401-409
25. Lin Z.B. Cellular and molecular mechanisms of immuno-modulation by Ganoderma lucidum. J Pharmacol Sci 99 (2005) 144-153